Corvex, Inc.
MOVE Nasdaq Services-Computer Processing & Data Preparation Financials FY2020βFY2025
What Corvex, Inc. does
No business description yet.
- Legal name
- Corvex, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 31, 2026
- Accession Β· CIK
- 0001213900-26-036609
0001734750
Revenue and margins
Corvex, Inc. had $0.4M of revenue in fiscal 2025, down 57.3% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Corvex, Inc. returned β to shareholders in fiscal 2025. The diluted share count rose 39.6%.
Balance sheet
Cash, debt and the ratios that show how comfortably Corvex, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $33.6M | $10.8M | $6.1M | $7.9M | $2.8M |
| Interest coverage | β22.4x | β38.1x | β | β | β5.2x |
| Current ratio | 10.9x | 2.3x | 1.4x | 3.0x | 0.6x |
| Quick ratio | 10.9x | 2.3x | 1.3x | 2.4x | 0.4x |
| Total assets | $36.3M | $13.2M | $9.4M | $11.3M | $5.6M |
| Total liabilities | $3.5M | $5.3M | $6.0M | $4.0M | $9.1M |
| Shareholders' equity | $32.7M | $7.9M | $3.4M | $7.4M | β$3.5M |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β |
| F-score | β / 3 | 4 / 7 | 2 / 7 | β / 6 | β / 6 | 1 / 8 |
| Accruals ratio | β33.4% | β25.8% | β21.9% | β27.4% | β11.5% | β82.9% |
| Altman Z'' | β26.87 | 5.99 | β34.00 | β61.78 | β51.06 | β120.34 |
6 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | β$1.9M | β$2.0M | $0.1M | β | $1.0M | $0.4M |
| Net interest income | β$1.9M | β$2.0M | $0.1M | β | β | β |
| Gross profit | β | β | β | β | β$2.0M | β$1.8M |
| Research and development | $8.4M | $13.4M | $19.0M | $16.9M | $11.2M | $5.7M |
| Operating income | β$11.1M | β$19.8M | β$30.5M | β$29.7M | β$24.2M | β$15.5M |
| Interest expense | $1.0M | $0.9M | $0.8M | β | β | $3.0M |
| Pretax income | β | β | β | β | β | β$18.3M |
| Net income | β$13.0M | β$21.8M | β$30.3M | β$29.3M | β$23.7M | β$18.3M |
| Net income to common | β$21.9M | β$24.3M | β$30.3M | β | β$23.7M | β$18.3M |
| Diluted EPS | β$6.85 | β$0.92 | β$0.92 | β$9.51 | β$39.39 | β$21.79 |
| Diluted shares | 0.00B | 0.03B | 0.03B | 0.00B | 0.00B | 0.00B |
| Cash flow | ||||||
| Cash from operations | β$10.7M | β$16.2M | β$24.9M | β$26.2M | β$22.5M | β$11.3M |
| Capital expenditure | β | $0.6M | $0.1M | $0.1M | $0.0M | β |
| Free cash flow | β | β$16.7M | β$25.0M | β$26.2M | β$22.5M | β |
| Depreciation and amortization | $0.0M | $0.1M | $0.1M | $0.2M | $0.2M | $0.1M |
| Stock-based compensation | $0.4M | $1.9M | $3.1M | $3.0M | $3.2M | $2.9M |
| Balance sheet | ||||||
| Cash and short-term investments | $5.7M | $33.6M | $10.8M | $6.1M | $7.9M | $2.8M |
| Finance lease liabilities | β | β | β | β | $0.7M | $0.5M |
| Current assets | $6.9M | $35.1M | $11.6M | $8.5M | $10.4M | $5.0M |
| Current liabilities | $1.2M | $3.2M | $5.0M | $5.9M | $3.4M | $8.8M |
| Inventory | β | β | β | $1.1M | $2.0M | $1.8M |
| Property and equipment, net | $0.0M | $0.5M | $0.4M | $0.3M | $0.2M | $0.1M |
| Total assets | $7.1M | $36.3M | $13.2M | $9.4M | $11.3M | $5.6M |
| Total liabilities | $15.1M | $3.5M | $5.3M | $6.0M | $4.0M | $9.1M |
| Preferred stock | β | β | β | β | β | $2.9M |
| Shareholders' equity | β$40.9M | $32.7M | $7.9M | $3.4M | $7.4M | β$3.5M |
| Margins | ||||||
| Gross margin | β | β | β | β | β196.8% | β424.9% |
| Operating margin | 577.3% | 1,005.2% | β22,903.8% | β | β2,391.1% | β3,580.4% |
| EBITDA margin | 576.6% | 1,001.5% | β22,793.2% | β | β2,374.7% | β3,546.0% |
| Net margin | 677.3% | 1,105.2% | β22,803.8% | β | β2,342.3% | β4,222.9% |
| FCF margin | β | 850.2% | β18,802.3% | β | β2,225.2% | β |
| Net interest share of revenue | 100.0% | 100.0% | 100.0% | β | β | β |
| Returns | ||||||
| Return on capital employed | β187.5% | β59.9% | β368.6% | β843.0% | β307.6% | 483.4% |
| Return on equity | β | β | β149.2% | β515.4% | β439.2% | β942.3% |
| Return on assets | β184.0% | β100.5% | β122.5% | β258.4% | β228.8% | β216.1% |
| Return on tangible equity | β | β74.1% | β383.2% | β849.0% | β322.6% | β |
| Growth | ||||||
| Revenue growth | β | β | β | β | β | β57.3% |
| Share count change | β | 721.5% | 25.6% | β90.7% | β80.4% | 39.6% |
| Financial health | ||||||
| Interest coverage | β11.1x | β22.4x | β38.1x | β | β | β5.2x |
| Current ratio | 5.9x | 10.9x | 2.3x | 1.4x | 3.0x | 0.6x |
| Quick ratio | 5.9x | 10.9x | 2.3x | 1.3x | 2.4x | 0.4x |
| Capital allocation | ||||||
| Capex / revenue | β | β28.7% | 78.9% | β | 0.8% | β |
| Stock comp / revenue | β23.2% | β94.1% | 2,327.8% | β | 318.4% | 672.7% |
| Quality scores | ||||||
| Piotroski F-score | β | 4.0 | 2.0 | β | β | 1.0 |
| Altman Z'' | β26.9 | 6.0 | β34.0 | β61.8 | β51.1 | β120.3 |
| Accruals ratio | β33.4% | β25.8% | β21.9% | β27.4% | β11.5% | β82.9% |
Source: SEC EDGAR XBRL filings (CIK 0001734750). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.